Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination
Mengran Zhang(Harvard University), Xiujun Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuexuan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hao Cai(Fudan University), Yue Du(Shandong University of Technology), Jianhua Gong(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Xu(University of California, Los Angeles)
Cited by 23
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145